NEUP - Rentabilitas dodolan miturut bathi resik Neuphoria Therapeutics

bionomics.com.au - logo grafis emiten NEUP

The net margin dynamics of commercial activities for Neuphoria Therapeutics Inc. (NEUP) correlate with expectations for the final trials of PTSD drugs, with the latest parameter standing at -423.30. The Australian startup focuses on creating innovative GABA-A modulators to combat depression. The stability of these studies is ensured by strict climate control during the transportation of biomaterials. Analysis of the chart allows for an assessment of the business's resilience to financial shocks.

bionomics.com.au (NEUP) - Tingkat bathi resik saka 25.12.2024 nganti 20.11.2026

bionomics.com.au (NEUP) - rincian metrik lan laporan keuangan

- rega saham lan konsensus proyeksi valuasi:
- statistik kapitalisasi pasar:
Analisis wiwitan perusahaan:Neuphoria Therapeutics Inc.
Produk asil prodhuksi Neuphoria Therapeutics Inc.

Neuphoria Therapeutics Inc. (NEUP) focuses on the costly development of PTSD medications, which generates colossal R&D expenses. Mathematically, these costs are deducted from revenue to determine the final remaining funds. This ratio measures the actual share of net profit in every dollar earned, revealing the efficiency of capital management. An analysis of the net profit margin allows for an assessment of the impact of operating expenses on profitability. The net profit margin trend reflects the company's current stage in its investment cycle.

Perusahaan pesaing

BIIB: Margin dodolan resik|Margin resik Neurocrine Biosciences Inc (NBIX)|RGC (Regencell Corp) - Margin dodolan resik|AXSM: Tingkat bathi resik|Margin resik acadia-pharm.com (ACAD)|Margin dodolan resik Xenon Pharmaceuticals (XENE)|Margin resik Viking Therapeutics VKTX|Tingkat bathi resik SUPN|CPRX - Margin resik|Margin resik Denali Therapeutics|HRMY: Margin dodolan resik|Biohaven - Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik AMLX|Trevi Therapeutics, Inc. (TRVI) - Margin dodolan perusahaan|Rentabilitas dodolan miturut bathi resik PRAX (Praxis Medicines)|Anavex Corp - Rentabilitas dodolan resik|Margin resik CeriBell CBLL|Margin dodolan perusahaan Prothena Biosciences (PRTA)|ALEC: Rentabilitas dodolan miturut bathi resik|ANNX - Margin dodolan resik|Omeros Corp. (OMER) - Margin resik|Margin resik Neurogene Inc. (NGNE)|Rentabilitas dodolan miturut bathi resik ACIU|Margin resik VYGR|Margin resik Neumora (NMRA)|SCLX - Margin resik|Margin dodolan resik TVGN (Tevogen Bio Holdings Inc.)|Tingkat bathi resik ACOG|Cognition Therapeutics Inc. - Margin dodolan resik|IKT - Margin dodolan resik|SAVA: Margin dodolan resik|Assertio Holdings, Inc. - Tingkat bathi resik|COYA (Coya) - Margin dodolan resik|Rentabilitas dodolan resik VTGN (Vistagen Therapeutics)|Margin resik Ovid Rx (OVID)|Acumen Pharmaceuticals - Rentabilitas dodolan resik|Margin resik CervoMed, Inc. CRVO|Margin dodolan resik Alterity Therapeutics ATHE|CLNN: Rentabilitas dodolan miturut bathi resik|PEPG (pepgen.com) - Rentabilitas dodolan resik|Jupiter Neurosciences Inc (JUNS) - Margin resik|Relmada Therapeutics - Tingkat bathi resik|ANVS (Annovis Bio Inc) - Margin dodolan resik|GRCE: Tingkat bathi resik|Margin resik Firefly Neuroscience Inc (AIFF)|KLTO (ANEW Medical) - Tingkat bathi resik|Margin resik neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Margin resik|MTVA: Rentabilitas dodolan miturut bathi resik|NeurAxis, Inc (NRXS) - Rentabilitas dodolan miturut bathi resik|HSDT: Margin dodolan resik|PASG - Margin dodolan perusahaan|Rentabilitas dodolan miturut bathi resik NERV|ATHA: Tingkat bathi resik|Margin resik Addex Therapeutics Ltd (ADXN)|ALZN (Alzamend Neuro Inc.) - Tingkat bathi resik|Margin dodolan resik CYCN (cyclerion.com)|Tingkat bathi miturut bathi resik Protagenic|KTTA: Rentabilitas dodolan miturut bathi resik|Tingkat bathi resik CRGT (cortigent.com)|ATXI: Margin dodolan resik|BCLI (BrainStorm Cell Therapeutics) - Margin resik|CARA (Cara Therapeutics Inc.) - Margin dodolan resik|Margin resik CHRO|Rentabilitas dodolan miturut bathi resik ELYM (Eliem Therapeutics)|Margin resik ITCI (Intra-Cellular Therapies Inc.)|Margin dodolan resik LBPH (Longboard Pharma)|Margin dodolan resik Marinus Pharmaceuticals Inc MRNS|NKGen Biotech Corp - Margin dodolan resik|Tingkat bathi resik NRBO (NeuroBo Pharma)|SAGE (Sage Therapeutics, Inc) - Rentabilitas dodolan miturut bathi resik|Rentabilitas dodolan resik SNPX|Rentabilitas dodolan miturut bathi resik TRVN|Margin resik VIGL|Margin dodolan resik WENA|Margin dodolan perusahaan Cerevel